Ave, I remember communicating with you about the lack of update on the submission to the FDA for the changes to the stage 2 phase 3 regarding dose, subjects, monitoring etc etc.
Whilst it was late (2 weeks) it was largely on time AND prior to the April quarterly. The quarterly was ok too, regarding spend.
I suspect Paul/Donna has everything they can, at hand now. And funding will be completed once the FDA ratify the changes suggested.
Im back on the PAR horse. But….. I am as nervous as other holders, now, too.
@Denial, how feel’n?
Ave, I remember communicating with you about the lack of update...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.5¢ |
Change
-0.005(1.92%) |
Mkt cap ! $89.19M | |||
| Open | High | Low | Value | Volume |
| 27.0¢ | 27.0¢ | 25.5¢ | $261.4K | 990.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9999 | 25.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 9445 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| PAR (ASX) Chart |